Related Experiment Video
Updated: Aug 27, 2025
07:09
A Surgical Model of Heart Failure with Preserved Ejection Fraction in Tibetan Minipigs
Published on: February 18, 2022
2.0K
Chronic Heart Failure: A Pharmacologic Review.
Shereen Salama1,2,3, Aeman Choudhury1,2,3, Sean P Kane1,2,3
1Shereen Salama, PharmD , PGY-2 Ambulatory Care Pharmacy Resident, Captain James A. Lovell Federal Health Care Center, North Chicago, IL.
Orthopedic Nursing
|September 27, 2022
Summary
Nurses play a vital role in managing chronic heart failure (CHF) by identifying at-risk patients and educating them on medication adherence. This article details essential CHF medications, side effects, and dosing for effective patient management.
Area of Science:
- Cardiology
- Pharmacology
- Nursing Practice
Background:
- Chronic heart failure (CHF) is a leading cause of hospitalization for individuals over 65 in the United States, impacting over 6 million Americans.
- Effective CHF management necessitates a collaborative, interdisciplinary approach involving physicians, nurses, and pharmacists.
- Nurses are crucial in early detection of CHF exacerbations and promoting patient adherence to prescribed treatments.
Purpose of the Study:
- To summarize current pharmacologic treatments for chronic heart failure.
- To outline common adverse effects associated with these medications.
- To provide essential dosing considerations and patient counseling points for healthcare providers.
Main Methods:
- Literature review of medications used in chronic heart failure management.
- Analysis of common side effects, dosing guidelines, and patient education strategies.
- Synthesis of information relevant to nursing practice in CHF care.
Main Results:
- Key medication classes for CHF are identified.
- Commonly observed side effects and their management are described.
- Dosing adjustments and critical counseling points are highlighted.
Conclusions:
- Comprehensive understanding of CHF medications is essential for nurses.
- Appropriate medication management, including adherence support, improves patient outcomes.
- Nurses are integral to optimizing pharmacotherapy in chronic heart failure.
Related Concept Videos
01:30Heart Failure V: Medical Management
21
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
21
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
488
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
488
01:22Heart Failure Drugs: β-Blockers
418
β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation,...
418
01:26Heart Failure Drugs: Inotropic Agents
691
Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
691
01:22Heart Failure Drugs: Diuretics
458
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
458
01:22Heart Failure VI: Adjunct Therapies
25
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
25